DoacsWarfarinSub
==============================

This study evaluated the comparative risk of severe uterine bleeding for rivaroxaban, apixaban, dabigatran, and warfarin therapies among propensity score-matched patients with non-valvular atrial fibrillation and venous thromboembolism in routine clinical practice.